v3.25.1
Net revenues (Tables)
3 Months Ended
Mar. 30, 2025
Revenue from Contract with Customer [Abstract]  
Schedule of revenue by major customers by reporting segments
The following table disaggregates revenue by global product category for the three months ended March 30, 2025 and March 31, 2024.
Three Months Ended
March 30, 2025March 31, 2024
Vascular access$182,367 $181,354 
Interventional
137,559 134,665 
Anesthesia86,594 96,352 
Surgical105,785 105,524 
Interventional urology70,967 79,742 
OEM63,884 87,697 
Other (1)
53,513 52,515 
Net revenues (2)
$700,669 $737,849 
(1)    Includes revenues generated from sales of our respiratory and urology products (other than interventional urology products).
(2)    The product categories listed above are presented on a global basis, as each of our reportable segments are defined based on the geographic location of its operations